The function and clinical significance of eIF3 in cancer
Y Yin, J Long, Y Sun, H Li, E Jiang, C Zeng, W Zhu - Gene, 2018 - Elsevier
Abnormal regulation of gene expression is essential for tumorigenesis. Several studies
indicate that regulation of oncogene expression and neoplastic transformation are controlled …
indicate that regulation of oncogene expression and neoplastic transformation are controlled …
eIF3a: a new anticancer drug target in the eIF family
Abstract eIF3a is the largest subunit of eIF3, which is a key player in all steps of translation
initiation. During the past years, eIF3a is recognized as a proto-oncogene, which is an …
initiation. During the past years, eIF3a is recognized as a proto-oncogene, which is an …
Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation
L Qin, Z Dong, C Huang, H Liu, J Beebe… - Cancer Letters, 2023 - Elsevier
Drug resistance is a major problem in cancer treatment with traditional or targeted
therapeutics. Gemcitabine is approved for several human cancers and the first line treatment …
therapeutics. Gemcitabine is approved for several human cancers and the first line treatment …
MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
Our previous studied indicated that eukaryotic translation initiation factor 3a (eIF3a)
increases the sensitive of platinum-based chemotherapy in lung cancer. MiRNAs play an …
increases the sensitive of platinum-based chemotherapy in lung cancer. MiRNAs play an …
eIF3a sustains non-small cell lung cancer stem cell-like properties by promoting YY1-mediated transcriptional activation of β-catenin
JY Zheng, T Zhu, W Zhuo, XY Mao, JY Yin, X Li… - Biochemical …, 2023 - Elsevier
Cancer stem cells (CSCs) are the leading cause of recurrence and poor prognosis in non-
small cell lung cancer (NSCLC). Eukaryotic translation initiation factor 3a (eIF3a) …
small cell lung cancer (NSCLC). Eukaryotic translation initiation factor 3a (eIF3a) …
Role of eIF3a in regulating cell cycle progression
Z Dong, Z Liu, P Cui, R Pincheira, Y Yang, J Liu… - Experimental cell …, 2009 - Elsevier
Translational control is an essential process in regulation of gene expression, which occurs
at the initiation step performed by a number of translation initiation factor complexes. eIF3a …
at the initiation step performed by a number of translation initiation factor complexes. eIF3a …
Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair
JY Yin, J Shen, ZZ Dong, Q Huang, MZ Zhong… - Clinical cancer …, 2011 - AACR
Purpose: The purpose of this study is to test the hypothesis that eIF3a may regulate the
expression of DNA repair proteins which, in turn, affects response of lung cancer patients to …
expression of DNA repair proteins which, in turn, affects response of lung cancer patients to …
Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)-and ribosomal protein S6K-mediated signals
B Kroczynska, S Kaur, E Katsoulidis… - … and cellular biology, 2009 - Taylor & Francis
Although the roles of Jak-Stat pathways in type I and II interferon (IFN)-dependent
transcriptional regulation are well established, the precise mechanisms of mRNA translation …
transcriptional regulation are well established, the precise mechanisms of mRNA translation …
Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma
M Lian, J Fang, D Han, H Ma, L Feng, R Wang, F Yang - PloS one, 2013 - journals.plos.org
Background Laryngeal squamous cell carcinoma (LSCC) is the most common type in head
and neck squamous cell carcinoma (HNSCC), and the development and progression of …
and neck squamous cell carcinoma (HNSCC), and the development and progression of …
[HTML][HTML] Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
N Golob-Schwarzl, C Schweiger, C Koller, S Krassnig… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most common cause of cancer related death worldwide.
Furthermore, with more than 1.2 million cases registered per year, it constitutes the third …
Furthermore, with more than 1.2 million cases registered per year, it constitutes the third …